Riskpilot← Back to searchSign inGet full accessMEDILINK A/S
A/SActiveCVR 19301540Klintehøj Vænge 6Wholesale of pharmaceutical and medical goods · NACE 4646Est. 19963 employees
Revenue 2025
DKK 112,3M
+900% vs 2024
EBITDA margin
96.4%
+1110% vs 2024
Equity ratio
24.1%
Financial strength
Net profit 2025
DKK 84,5M
+1127% vs 2024
| Revenue | DKK 112,3M | +900% |
| EBITDA | DKK 108,2M | +1110% |
| Net profit | DKK 84,5M | +1127% |
| Total assets | DKK 49,1M | +166% |
| Equity | DKK 11,8M | +33% |
| Employees | 3 | — |
Legal name
MEDILINK A/S
CVR number
19301540
Legal form
Aktieselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
28. maj 1996
Share capital
DKK 1.000.000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør alene eller af to bestyrelsesmedlemmer i forening.
Company purpose
Selskabets formål er at drive handels- og konsulentvirksomhed indenfor sundhedssektoren.
Address
Klintehøj Vænge 6
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.005 | -752 | 4.789 | 1.354 | 5.730 | 5.946 | 11.781 | 14.983 | 18.871 | 18.096 | 9.983 | 11.357 | 11.228 | 112.266 |
| Staff expenses | -1.538 | -2.580 | -3.782 | -4.363 | -3.915 | -4.465 | -4.622 | -6.209 | -5.738 | -1.699 | -2.013 | -2.431 | -2.286 | -4.072 |
| EBITDA | 467 | -3.332 | 1.007 | -3.009 | 1.815 | 1.480 | -2.306 | 621 | 2.787 | 6.379 | 7.970 | 8.926 | 8.943 | 108.194 |
| Depreciation & amort. | -83 | -168 | -115 | -142 | -170 | -108 | -0 | -0 | -0 | -0 | -104 | -103 | -47 | -21 |
| EBIT | 384 | -3.500 | 892 | -3.151 | 1.645 | 1.373 | -2.306 | 621 | 2.787 | 6.379 | 7.866 | 8.824 | 8.896 | 108.173 |
| Net financials | -28 | -201 | -479 | -394 | -186 | -111 | -79 | -166 | -325 | -43 | -27 | 199 | -128 | 295 |
| Profit before tax | 356 | -3.701 | 413 | -3.545 | 1.459 | 1.262 | -2.385 | 456 | 2.462 | 6.337 | 7.839 | 9.022 | 8.768 | 108.468 |
| Tax | 102 | -912 | 109 | -833 | 330 | 283 | -510 | 112 | 549 | 1.356 | 1.705 | 1.980 | 1.884 | 24.006 |
| Net profit | 254 | -2.789 | 304 | -2.712 | 1.129 | 979 | -1.875 | 344 | 1.913 | 4.980 | 6.134 | 7.042 | 6.884 | 84.463 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 12.511 | 16.268 | 18.115 | 17.853 | 17.094 | 17.220 | 19.572 | 20.044 | 18.131 | 21.720 | 23.504 | 28.420 | 18.435 | 49.078 |
| Equity | 4.029 | 1.241 | 1.545 | 6.833 | 7.962 | 8.941 | 7.066 | 7.410 | 9.323 | 13.803 | 9.937 | 8.979 | 8.863 | 11.825 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 8.467 | 15.027 | 16.570 | 10.960 | 9.089 | 8.247 | 12.458 | 12.586 | 8.766 | 7.888 | 13.552 | 19.441 | 9.572 | 37.253 |
| Total debt | 8.467 | 15.027 | 16.570 | 10.960 | 9.089 | 8.247 | 12.458 | 12.586 | 8.766 | 7.888 | 13.552 | 19.441 | 9.572 | 37.253 |
EBITDA margin
96.4%
This company
15.8%
Market median
+510% vs market
20122025
Equity ratio
24.1%
This company
38.2%
Market median
-37% vs market
20122025
Return on equity
714.3%
This company
18.4%
Market median
+3782% vs market
20122025
Net profit margin
75.2%
This company
8.1%
Market median
+828% vs market
20122025
Asset turnover
2.29×
This company
1.12×
Market median
+104% vs market
20122025
Debt / equity
3.15×
This company
0.62×
Market median
-408% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via CVR / Virk · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via CVR / Virk · Period 2018-07-01 – 2019-06-30
- Annual report 2018Filed via CVR / Virk · Period 2017-07-01 – 2018-06-30
- Annual report 2017Filed via CVR / Virk · Period 2016-07-01 – 2017-06-30
- Annual report 2016Filed via CVR / Virk · Period 2015-07-01 – 2016-06-30
- Annual report 2015Filed via CVR / Virk · Period 2014-07-01 – 2015-06-30
- Annual report 2014Filed via CVR / Virk · Period 2013-07-01 – 2014-06-30
- Annual report 2013Filed via CVR / Virk · Period 2012-07-01 – 2013-06-30
- Annual report 2012Filed via CVR / Virk · Period 2011-07-01 – 2012-06-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
ET | Audit | 1996 | — | — |
| Audit | 2001 | — | — | |
CK Management | Management | 2008 | — | — |
MF Chief Executive Officer | Chief Executive Officer | 2008 | — | — |
PE Management | Management | 1996 | — | — |
FL Management | Management | 1996 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2017 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2010 | — | — | |
| Board of Directors | 2010 | — | — | |
| Chairman | 2025 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 1997 | — | — | |
| Chairman | 1997 | — | — | |
| Board of Directors | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
BIBAWO FC Holding ApS | Company | 100.0% | 100.0% | 2025 |
DOC ApS | Company | 100.0% | 100.0% | 2015 |
DOC-BIBAWO ApS | Company | 100.0% | 100.0% | 2018 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
BIBAWO FC Holding ApS
MEDILINK A/S Board members of MEDILINK A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Erik Tronborg Andersen | Audit | 0 companies |
| DL Revisions- & Konsulentfirma Statsautoriserede Revisorer | Audit | 0 companies |
| Christian Kjerulf-Jensen | Management | 0 companies |
| Michael Frederik Treschow | Chief Executive Officer | 0 companies |
| Per Emil Hasselbalch Stakemann | Management | 0 companies |
| Finn Leerbeck | Management | 0 companies |
| Ole Kjerulf-Jensen | Board of Directors | 0 companies |
| Tanya Arp Regnersgaard | Board of Directors | 0 companies |
| Bent Sørensen Kjærsgaard | Board of Directors | 0 companies |
| Dorthe Kjerulf | Board of Directors | 0 companies |
| Kim Domela Kjøller | Chairman | 0 companies |
| Morten Lind Jensen | Board of Directors | 0 companies |
| Svend Bernt Hagemann | Board of Directors | 0 companies |
| Lars Heslet | Board of Directors | 0 companies |
| Niels Ulrik Heine | Chairman | 0 companies |
| Frederik Kjerulf-Jensen | Board of Directors | 0 companies |